Influenza
From the Journals
Inactivated flu vaccine succeeds among autoimmune rheumatic disease patients
Safety and effectiveness data support use of inactivated flu vaccine for individuals with autoimmune rheumatic diseases.
News from the FDA/CDC
After weeks of decline, influenza activity increases slightly
Attention on COVID-19 may have led to more visits than usual for respiratory illness.
News from the FDA/CDC
Flu activity declines again but remains high
Number of deaths in children at this point in the season is the highest seen since the 2009 pandemic.
News from the FDA/CDC
Children bearing the brunt of declining flu activity
CDC invokes the 2009 pandemic when referring to the latest data on pediatric deaths and hospitalizations.
News
ACIP: Flu vaccines for older adults show similar safety profiles
Comparison of two approved flu vaccines for adults 65 and older yielded similar safety and quality of life results.
News from the FDA/CDC
Drop in flu activity suggests season may have peaked
News from the FDA/CDC
Flu increases activity but not its severity
A very red map now has 41 states at the highest level of influenza activity.
News from the FDA/CDC
Flu activity increases for third straight week
One important indicator – outpatient visits – is headed into uncharted territory.
News
FDA approves novel pandemic influenza vaccine
This is the first and only adjuvanted, cell-based pandemic vaccine to provide active immunization against influenza A virus H5N1 strain.
News from the FDA/CDC
Don’t forget about the flu: 2019-2020 season is not over
Activity levels continue to rise after a 2-week drop at the beginning of the year.
News from the FDA/CDC
Flu activity declines for second straight week